Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with AGN as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|8.39%||IQ Merger Arbitrage ETF (MNA)||+0.96 (3.46%)|
|5.26%||iShares U.S. Pharmaceutical ETF (IHE)||+28.75 (20.37%)|
|4.72%||Market Vectors Pharmaceutical ETF (PPH)||+6.18 (9.79%)|
|3.62%||iShares MSCI Netherlands Index Fund (EWN)||+1.79 (7.54%)|
|2.33%||First Trust Health Care AlphaDEX (FXH)||+8.87 (15.75%)|
Company Description (as filed with the SEC)
We are a multi-specialty health care company focused on developing and commercializing innovative pharmaceuticals, biologics, medical devices and over-the-counter products that enable people to live life to its full potential - to see more clearly, move more freely and express themselves more fully. We discover, develop and commercialize a diverse range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets in more than 100 countries around the world. We are also a pioneer in specialty pharmaceutical, biologic and medical device research and development. Our research and development efforts are focused on products and technologies related to the many specialty areas in which we currently operate as well as new specialty areas where unmet medical needs are significant. ... More ...
Where does AGN fit in the risk graph?
|Annual EPS Est:||$6.65|
|Quarterly EPS Est:||1.79|